biotech

Diagnostic stocks making a charge

Claire Aitchison

Independent Investment Research

Platinum: There's a revolution in biotech and you need to be part of it

Livewire Markets

Regal's Dr Craig Collie: Diagnosing financial markets

Koda Capital

3 biotechs changing the future of healthcare

Dr Bianca Ogden

Platinum Asset Management

Deep Value & Positive Catalysts

Fiftyone Capital

Technology is reshaping modern medicine

Michael Collins

Magellan

Our take on Paradigm, one of Livewire's most-tipped small caps

Fiftyone Capital

The New Criterion: two ways to play the pain game

Independent Investment Research

Paradigm: Deep value in a small-cap biotech?

Livewire Exclusive

Livewire Markets

Alzheimer's: No Surprises

Frazis Capital Partners